ID: ALA4531187

Max Phase: Preclinical

Molecular Formula: C40H41N7O6S3

Molecular Weight: 812.01

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc2c(cc1OCCCC(=O)Nc1cn(C)c(C(=O)Nc3ccc4sc(C(=O)NCC(C)(C)SSC)cc4c3)n1)N=C[C@@H]1Cc3ccccc3N1C2=O

Standard InChI:  InChI=1S/C40H41N7O6S3/c1-40(2,56-54-5)22-42-37(49)33-17-24-15-25(12-13-32(24)55-33)43-38(50)36-45-34(21-46(36)3)44-35(48)11-8-14-53-31-19-28-27(18-30(31)52-4)39(51)47-26(20-41-28)16-23-9-6-7-10-29(23)47/h6-7,9-10,12-13,15,17-21,26H,8,11,14,16,22H2,1-5H3,(H,42,49)(H,43,50)(H,44,48)/t26-/m0/s1

Standard InChI Key:  YDAOFQBPUHTSEY-SANMLTNESA-N

Associated Targets(Human)

NAMALVA 207 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 812.01Molecular Weight (Monoisotopic): 811.2280AlogP: 7.50#Rotatable Bonds: 14
Polar Surface Area: 156.25Molecular Species: NEUTRALHBA: 12HBD: 3
#RO5 Violations: 3HBA (Lipinski): 13HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.39CX Basic pKa: 3.77CX LogP: 5.86CX LogD: 5.86
Aromatic Rings: 5Heavy Atoms: 56QED Weighted: 0.08Np Likeness Score: -0.85

References

1. Reid EE, Archer KE, Shizuka M, McShea MA, Maloney EK, Ab O, Lanieri L, Wilhelm A, Ponte JF, Yoder NC, Chari RVJ, Miller ML..  (2019)  Design, synthesis and evaluation of novel, potent DNA alkylating agents and their antibody-drug conjugates (ADCs).,  29  (17): [PMID:31350125] [10.1016/j.bmcl.2019.07.031]

Source